{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:49:01Z","timestamp":1787496541455,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kyowa Kirin"},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    X-linked hypophosphatemia (XLH) is the most common inherited form of hypophosphatemic rickets. Children with XLH have an increased risk of obesity, which may promote high blood pressure, but data on blood pressure in XLH are inconclusive. We aimed to assess blood pressure and its determinants in pediatric XLH patients. We conduct a prospective, multicenter observational study of children with XLH in Germany and Switzerland. Office blood pressure and body mass index (BMI) were annually measured in 128 pediatric XLH patients with a median follow-up of 2\u00a0years (range 1\u20136). Potential predictors of blood pressure were investigated by Spearman correlation. Seventeen percent of patients were treated with phosphate supplements and active vitamin D for a median of 8\u00a0years, 83% of patients received burosumab for 2.3\u00a0years with 3.1\u00a0years of prior treatment with phosphate supplements and active vitamin D. Median systolic (0.75 z-score) and diastolic (0.32 z-score) blood pressure and BMI (0.72 z-score) were increased compared to healthy children (each\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01). The prevalence of obesity (9.8% vs. 3%), arterial hypertension (26.2% vs. 5%), and high-normal blood pressure (22.9% vs. 5%) was higher in the XLH cohort compared to the general pediatric population (each\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Spearman rank correlation analysis revealed significant associations between both systolic (r\u2009=\u20090.24;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01) and diastolic (r\u2009=\u20090.20;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05) blood pressure with BMI, while the mode of treatment, i.e. burosumab versus phosphate supplements and active vitamin D, was no significant correlate. Children with XLH present with elevated office blood pressure values, associated with elevated BMI.\n                  <\/jats:p>","DOI":"10.1007\/s00223-025-01363-z","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T15:18:56Z","timestamp":1743347936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Office Blood Pressure and Obesity in Children with X-Linked Hypophosphatemia"],"prefix":"10.1007","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0979-6382","authenticated-orcid":false,"given":"Ineke","family":"B\u00f6ckmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Leifheit-Nestler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Rehberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Spart\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Peter","family":"Schlingmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J.","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Richter-Unruh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Hiort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Grohmann-Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Derichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Freiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Dunstheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"John-Kroegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Metzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Heger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Jorch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagen","family":"Staude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Patzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"W\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Zivicnjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9601-7813","authenticated-orcid":false,"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the German Society for Pediatric Nephrology (GPN) and the German Society for Pediatric and Adolescent Endocrinology and Diabetology (DGPAED)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"1363_CR1","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"TO Carpenter","year":"2011","unstructured":"Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL (2011) A clinician\u2019s guide to X-linked hypophosphatemia. J Bone Miner Res 26:1381\u20131388. https:\/\/doi.org\/10.1002\/jbmr.340","journal-title":"J Bone Miner Res"},{"key":"1363_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/eje-08-0818","volume":"160","author":"SS Beck-Nielsen","year":"2009","unstructured":"Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK (2009) Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol 160:491\u2013497. https:\/\/doi.org\/10.1530\/eje-08-0818","journal-title":"Eur J Endocrinol"},{"key":"1363_CR3","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1507\/endocrj.ej15-0275","volume":"62","author":"I Endo","year":"2015","unstructured":"Endo I, Fukumoto S, Ozono K, Namba N, Inoue D, Okazaki R, Yamauchi M, Sugimoto T, Minagawa M, Michigami T, Nagai M, Matsumoto T (2015) Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment. Endocr J 62:811\u2013816. https:\/\/doi.org\/10.1507\/endocrj.ej15-0275","journal-title":"Endocr J"},{"key":"1363_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","volume":"14","author":"SS Beck-Nielsen","year":"2019","unstructured":"Beck-Nielsen SS, Mughal Z, Haffner D, Nilsson O, Levtchenko E, Ariceta G, de Lucas CC, Schnabel D, Jandhyala R, M\u00e4kitie O (2019) FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J Rare Dis 14:58. https:\/\/doi.org\/10.1186\/s13023-019-1014-8","journal-title":"Orphanet J Rare Dis"},{"key":"1363_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","volume":"15","author":"D Haffner","year":"2019","unstructured":"Haffner D, Emma F, Eastwood DM, Duplan MB, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A (2019) Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol 15:435\u2013455. https:\/\/doi.org\/10.1038\/s41581-019-0152-5","journal-title":"Nat Rev Nephrol"},{"key":"1363_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13023-023-02882-4","volume":"18","author":"G Ariceta","year":"2023","unstructured":"Ariceta G, Beck-Nielsen SS, Boot AM, Brandi ML, Briot K, de Lucas CC, Emma F, Giannini S, Haffner D, Keen R, Levtchenko E, M\u04d3kitie O, Mughal MZ, Nilsson O, Schnabel D, Tripto-Shkolnik L, Liu J, Williams A, Wood S, Zillikens MC (2023) The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data. Orphanet J Rare Dis 18:304. https:\/\/doi.org\/10.1186\/s13023-023-02882-4","journal-title":"Orphanet J Rare Dis"},{"key":"1363_CR7","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1056\/nejm199112263252604","volume":"325","author":"CF Verge","year":"1991","unstructured":"Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M (1991) Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325:1843\u20131848. https:\/\/doi.org\/10.1056\/nejm199112263252604","journal-title":"N Engl J Med"},{"key":"1363_CR8","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/jbmr.3992","volume":"35","author":"AL Lecoq","year":"2020","unstructured":"Lecoq AL, Chaumet-Riffaud P, Blanchard A, Dupeux M, Rothenbuhler A, Lambert B, Durand E, Boros E, Briot K, Silve C, Francou B, Piketty M, Chanson P, Brailly-Tabard S, Linglart A, Kamenick\u00fd P (2020) Hyperparathyroidism in patients with X-linked hypophosphatemia. J Bone Miner Res 35:1263\u20131273. https:\/\/doi.org\/10.1002\/jbmr.3992","journal-title":"J Bone Miner Res"},{"key":"1363_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziad001","author":"LM Ward","year":"2024","unstructured":"Ward LM, H\u00f6gler W, Glorieux FH, Portale AA, Whyte MP, Munns CF, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Sochett E, Muroya K, Tanaka H, Pitukcheewanont P, Gottesman GS, Biggin A, Perwad F, Chen A, Lawrence Merritt Ii J, Imel EA (2024) Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period. JBMR Plus. https:\/\/doi.org\/10.1093\/jbmrpl\/ziad001","journal-title":"JBMR Plus"},{"key":"1363_CR10","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/jci46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Guti\u00e9rrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro OM, Kusek JW, Keane MG, Wolf M (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121:4393\u20134408. https:\/\/doi.org\/10.1172\/jci46122","journal-title":"J Clin Invest"},{"key":"1363_CR11","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/ndt\/gfv421","volume":"31","author":"M Leifheit-Nestler","year":"2016","unstructured":"Leifheit-Nestler M, Gro\u00dfe Siemer R, Flasbart K, Richter B, Kirchhoff F, Ziegler WH, Klintschar M, Becker JU, Erbersdobler A, Aufricht C, Seeman T, Fischer DC, Faul C, Haffner D (2016) Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease. Nephrol Dial Transplant 31:1088\u20131099. https:\/\/doi.org\/10.1093\/ndt\/gfv421","journal-title":"Nephrol Dial Transplant"},{"key":"1363_CR12","doi-asserted-by":"publisher","first-page":"e93423","DOI":"10.1371\/journal.pone.0093423","volume":"9","author":"I Six","year":"2014","unstructured":"Six I, Okazaki H, Gross P, Cagnard J, Boudot C, Maizel J, Drueke TB, Massy ZA (2014) Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium. PLoS ONE 9:e93423. https:\/\/doi.org\/10.1371\/journal.pone.0093423","journal-title":"PLoS ONE"},{"key":"1363_CR13","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1038\/s41598-024-56377-8","volume":"14","author":"CDK Wungu","year":"2024","unstructured":"Wungu CDK, Susilo H, Alsagaff MY, Witarto BS, Witarto AP, Pakpahan C, Gusnanto A (2024) Role of klotho and fibroblast growth factor 23 in arterial calcification, thickness, and stiffness: a meta-analysis of observational studies. Sci Rep 14:5712. https:\/\/doi.org\/10.1038\/s41598-024-56377-8","journal-title":"Sci Rep"},{"key":"1363_CR14","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1210\/jc.2009-1671","volume":"95","author":"EA Imel","year":"2010","unstructured":"Imel EA, DiMeglio LA, Hui SL, Carpenter TO, Econs MJ (2010) Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab 95:1846\u20131850. https:\/\/doi.org\/10.1210\/jc.2009-1671","journal-title":"J Clin Endocrinol Metab"},{"key":"1363_CR15","doi-asserted-by":"publisher","first-page":"204201882110011","DOI":"10.1177\/20420188211001150","volume":"12","author":"A Brener","year":"2021","unstructured":"Brener A, Lebenthal Y, Cleper R, Kapusta L, Zeitlin L (2021) Body composition and cardiometabolic health of pediatric patients with X-linked hypophosphatemia (XLH) under burosumab therapy. Ther Adv Endocrinol Metab 12:20420188211001150. https:\/\/doi.org\/10.1177\/20420188211001150","journal-title":"Ther Adv Endocrinol Metab"},{"key":"1363_CR16","doi-asserted-by":"publisher","first-page":"1400273","DOI":"10.3389\/fendo.2024.1400273","volume":"15","author":"A Brener","year":"2024","unstructured":"Brener A, Cleper R, Baruch G, Rothschild E, Yackobovitch-Gavan M, Beer G, Zeitlin L, Kapusta L (2024) Cardiovascular health in pediatric patients with X-linked hypophosphatemia under two years of burosumab therapy. Front Endocrinol (Lausanne) 15:1400273. https:\/\/doi.org\/10.3389\/fendo.2024.1400273","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1363_CR17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00467-022-05636-9","volume":"38","author":"L Bloudeau","year":"2023","unstructured":"Bloudeau L, Linglart A, Flammier S, Portefaix A, Bertholet-Thomas A, Eddiry S, Barosi A, Salles JP, Porquet-Bordes V, Rothenbuhler A, Roger C, Bacchetta J (2023) X-linked hypophosphatemia, obesity and arterial hypertension: data from the XLH21 study. Pediatr Nephrol 38:697\u2013704. https:\/\/doi.org\/10.1007\/s00467-022-05636-9","journal-title":"Pediatr Nephrol"},{"key":"1363_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1530\/ec-19-0481","volume":"9","author":"VV Zhukouskaya","year":"2020","unstructured":"Zhukouskaya VV, Rothenbuhler A, Colao A, Di Somma C, Kamenick\u00fd P, Trabado S, Pri\u00e9 D, Audrain C, Barosi A, Kyheng C, Lambert AS, Linglart A (2020) Increased prevalence of overweight and obesity in children with X-linked hypophosphatemia. Endocr Connect 9:144\u2013153. https:\/\/doi.org\/10.1530\/ec-19-0481","journal-title":"Endocr Connect"},{"key":"1363_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1507\/endocrj.ej16-0199","volume":"64","author":"Y Nakamura","year":"2017","unstructured":"Nakamura Y, Takagi M, Takeda R, Miyai K, Hasegawa Y (2017) Hypertension is a characteristic complication of X-linked hypophosphatemia. Endocr J 64:283\u2013289. https:\/\/doi.org\/10.1507\/endocrj.ej16-0199","journal-title":"Endocr J"},{"key":"1363_CR20","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1210\/clinem\/dgac543","volume":"107","author":"MN M\u00e9aux","year":"2022","unstructured":"M\u00e9aux MN, Alioli C, Linglart A, Lemoine S, Vignot E, Bertholet-Thomas A, Peyruchaud O, Flammier S, Machuca-Gayet I, Bacchetta J (2022) X-Linked Hypophosphatemia, Not Only a Skeletal Disease But Also a Chronic Inflammatory State. J Clin Endocrinol Metab 107:3275\u20133286. https:\/\/doi.org\/10.1210\/clinem\/dgac543","journal-title":"J Clin Endocrinol Metab"},{"key":"1363_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/jbmr.5650050508","volume":"5","author":"I Vered","year":"1990","unstructured":"Vered I, Vered Z, Perez JE, Jaffe AS, Whyte MP (1990) Normal left ventricular performance in children with X-linked hypophosphatemic rickets: a Doppler echocardiography study. J Bone Miner Res 5:469\u2013474. https:\/\/doi.org\/10.1002\/jbmr.5650050508","journal-title":"J Bone Miner Res"},{"key":"1363_CR22","doi-asserted-by":"publisher","first-page":"e488","DOI":"10.1210\/clinem\/dgad608","volume":"109","author":"A Bouzemane","year":"2024","unstructured":"Bouzemane A, Vignot E, Derain Dubourg L, De Mul A, Molin A, Chapurlat R, Fontanges E, Delsart D, Akbari A, Huang SHS, McIntyre CW, Bacchetta J, Lemoine S (2024) Reassuring data on the cardiovascular risk in adults with X-linked hypophosphatemia receiving conventional therapy. J Clin Endocrinol Metab 109:e488\u2013e494. https:\/\/doi.org\/10.1210\/clinem\/dgad608","journal-title":"J Clin Endocrinol Metab"},{"key":"1363_CR23","doi-asserted-by":"publisher","first-page":"e998","DOI":"10.1210\/clinem\/dgad223","volume":"108","author":"A Ewert","year":"2023","unstructured":"Ewert A, Rehberg M, Schlingmann KP, Hiort O, John-Kroegel U, Metzing O, W\u00fchl E, Schaefer F, Kemper MJ, Derichs U, Richter-Unruh A, Patzer L, Albers N, Dunstheimer D, Haberland H, Heger S, Schr\u00f6der C, Jorch N, Schmid E, Staude H, Weitz M, Freiberg C, Leifheit-Nestler M, Zivicnjak M, Schnabel D, Haffner D (2023) Effects of Burosumab Treatment on Mineral Metabolism in Children and Adolescents With X-linked Hypophosphatemia. J Clin Endocrinol Metab 108:e998\u2013e1006. https:\/\/doi.org\/10.1210\/clinem\/dgad223","journal-title":"J Clin Endocrinol Metab"},{"key":"1363_CR24","unstructured":"Kyowa Kirin (2018) Annex I - Summary of Product Characteristics."},{"key":"1363_CR25","unstructured":"Kyowa Kirin K (2022) Annex I - Summary of Product Characteristics."},{"key":"1363_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s15006-022-2047-9","volume":"164","author":"E W\u00fchl","year":"2022","unstructured":"W\u00fchl E, Dalla Pozza R (2022) Arterial hypertension in children and adolescents. Diagnostics, therapy and prevention. MMW Fortschr Med 164:58\u201361. https:\/\/doi.org\/10.1007\/s15006-022-2047-9","journal-title":"MMW Fortschr Med"},{"key":"1363_CR27","unstructured":"Wabitsch M (2019) Therapie und Pr\u00e4vention der Adipositas im Kindes-und Jugendalter. AWMF online. https:\/\/register.awmf.org\/assets\/guidelines\/050-002l_S3_Therapie-Praevention-Adipositas-Kinder-Jugendliche_2019-11.pdf"},{"key":"1363_CR28","doi-asserted-by":"publisher","unstructured":"Neuhauser H, Schienkiewitz A, Rosario AS, Dortschy R, Kurth B-M (2013) Referenzperzentile f\u00fcr anthropometrische Ma\u00dfzahlen und Blutdruck aus der Studie zur Gesundheit von Kindern und Jugendlichen in Deutschland (KiGGS). In:Robert Koch-Institut https:\/\/doi.org\/10.25646\/3179.","DOI":"10.25646\/3179"},{"key":"1363_CR29","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s001120170107","volume":"149","author":"K Kromeyer-Hauschild","year":"2001","unstructured":"Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Gei\u00df HC, Hesse V, von Hippel A, Jaeger U, Johnsen D, Korte W, Menner K, M\u00fcller G, M\u00fcller JM, Niemann-Pilatus A, Remer T, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Ziegler A, Hebebrand J (2001) Perzentile f\u00fcr den Body-mass-Index f\u00fcr das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschrift Kinderheilkunde 149:807\u2013818. https:\/\/doi.org\/10.1007\/s001120170107","journal-title":"Monatsschrift Kinderheilkunde"},{"key":"1363_CR30","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1210\/clinem\/dgad597","volume":"109","author":"V Pott","year":"2024","unstructured":"Pott V, Tietze H, Kanzelmeyer N, von der Born J, Baumann U, Mindermann C, Suhlrie A, Drube J, Melk A, Das AM, Schnabel D, Haffner D, Leifheit-Nestler M (2024) LMS-based pediatric reference values for parameters of phosphate homeostasis in the HARP cohort. J Clin Endocrinol Metab 109:668\u2013679. https:\/\/doi.org\/10.1210\/clinem\/dgad597","journal-title":"J Clin Endocrinol Metab"},{"key":"1363_CR31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/10408363.2017.1379945","volume":"54","author":"K Adeli","year":"2017","unstructured":"Adeli K, Higgins V, Trajcevski K, White-Al Habeeb N (2017) The Canadian laboratory initiative on pediatric reference intervals: a CALIPER white paper. Crit Rev Clin Lab Sci 54:358\u2013413. https:\/\/doi.org\/10.1080\/10408363.2017.1379945","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1363_CR32","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00467-021-05328-w","volume":"37","author":"D Haffner","year":"2022","unstructured":"Haffner D, Leifheit-Nestler M, Grund A, Schnabel D (2022) Rickets guidance: part I-diagnostic workup. Pediatr Nephrol 37:2013\u20132036. https:\/\/doi.org\/10.1007\/s00467-021-05328-w","journal-title":"Pediatr Nephrol"},{"key":"1363_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/asn.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637. https:\/\/doi.org\/10.1681\/asn.2008030287","journal-title":"J Am Soc Nephrol"},{"key":"1363_CR34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/s0895-7061(97)00493-7","volume":"11","author":"E Lurbe","year":"1998","unstructured":"Lurbe E, Alvarez V, Liao Y, Tacons J, Cooper R, Cremades B, Torro I, Red\u00f3n J (1998) The impact of obesity and body fat distribution on ambulatory blood pressure in children and adolescents. Am J Hypertens 11:418\u2013424. https:\/\/doi.org\/10.1016\/s0895-7061(97)00493-7","journal-title":"Am J Hypertens"},{"key":"1363_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1161\/hypertensionaha.118.11872","volume":"73","author":"S K\u00f6chli","year":"2019","unstructured":"K\u00f6chli S, Endes K, Steiner R, Engler L, Infanger D, Schmidt-Trucks\u00e4ss A, Zahner L, Hanssen H (2019) Obesity, high blood pressure, and physical activity determine vascular phenotype in young children. Hypertension 73:153\u2013161. https:\/\/doi.org\/10.1161\/hypertensionaha.118.11872","journal-title":"Hypertension"},{"key":"1363_CR36","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00467-018-4180-3","volume":"34","author":"O Hern\u00e1ndez-Fr\u00edas","year":"2019","unstructured":"Hern\u00e1ndez-Fr\u00edas O, Gil-Pe\u00f1a H, P\u00e9rez-Rold\u00e1n JM, Gonz\u00e1lez-Sanchez S, Ariceta G, Chocr\u00f3n S, Loza R, de la Cerda OF, Madariaga L, Vergara I, Fern\u00e1ndez-Fern\u00e1ndez M, Ferrando-Monle\u00f3n S, Ant\u00f3n-Gamero M, Fern\u00e1ndez-Maseda \u00c1, Luis-Yanes MI, Santos F (2019) Risk of cardiovascular involvement in pediatric patients with X-linked hypophosphatemia. Pediatr Nephrol 34:1077\u20131086. https:\/\/doi.org\/10.1007\/s00467-018-4180-3","journal-title":"Pediatr Nephrol"},{"key":"1363_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-024-06427-0","author":"M Klein","year":"2024","unstructured":"Klein M, Obermaier M, Mutze H, Wilden SM, Rehberg M, Schlingmann KP, Schmidt D, Metzing O, H\u00fcbner A, Richter-Unruh A, Kemper MJ, Weitz M, W\u00fchl E, Jorch N, Patzer L, Freiberg C, Heger S, Ziviknjak M, Schnabel D, Haffner D (2024) Health-related quality of life of children with X-linked hypophosphatemia in Germany. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-024-06427-0","journal-title":"Pediatr Nephrol"},{"key":"1363_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071691","author":"N Latic","year":"2022","unstructured":"Latic N, Zupcic A, Frauenstein D, Erben RG (2022) Activation of RAAS signaling contributes to hypertension in aged hyp mice. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10071691","journal-title":"Biomedicines"},{"key":"1363_CR39","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/emmm.201303716","volume":"6","author":"O Andrukhova","year":"2014","unstructured":"Andrukhova O, Slavic S, Smorodchenko A, Zeitz U, Shalhoub V, Lanske B, Pohl EE, Erben RG (2014) FGF23 regulates renal sodium handling and blood pressure. EMBO Mol Med 6:744\u2013759. https:\/\/doi.org\/10.1002\/emmm.201303716","journal-title":"EMBO Mol Med"},{"key":"1363_CR40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fendo.2018.00333","volume":"9","author":"M Leifheit-Nestler","year":"2018","unstructured":"Leifheit-Nestler M, Richter B, Basaran M, Nespor J, Vogt I, Alesutan I, Voelkl J, Lang F, Heineke J, Krick S, Haffner D (2018) Impact of altered mineral metabolism on pathological cardiac remodeling in elevated fibroblast growth factor 23. Front Endocrinol (Lausanne) 9:333. https:\/\/doi.org\/10.3389\/fendo.2018.00333","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1363_CR41","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1210\/jcem.82.8.4181","volume":"82","author":"R Nehgme","year":"1997","unstructured":"Nehgme R, Fahey JT, Smith C, Carpenter TO (1997) Cardiovascular abnormalities in patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 82:2450\u20132454. https:\/\/doi.org\/10.1210\/jcem.82.8.4181","journal-title":"J Clin Endocrinol Metab"},{"key":"1363_CR42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/ndt\/gfac220","volume":"38","author":"N Vergara","year":"2023","unstructured":"Vergara N, de Mier MVP, Rodelo-Haad C, Revilla-Gonz\u00e1lez G, Membrives C, D\u00edaz-Tocados JM, Mart\u00ednez-Moreno JM, Torralbo AI, Herencia C, Rodr\u00edguez-Ortiz ME, L\u00f3pez-Baltan\u00e1s R, Richards WG, Felsenfeld A, Almad\u00e9n Y, Martin-Malo A, Ure\u00f1a J, Santamar\u00eda R, Soriano S, Rodr\u00edguez M, Mu\u00f1oz-Casta\u00f1eda JR (2023) The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function. Nephrol Dial Transplant 38:322\u2013343. https:\/\/doi.org\/10.1093\/ndt\/gfac220","journal-title":"Nephrol Dial Transplant"},{"key":"1363_CR43","doi-asserted-by":"publisher","first-page":"12398","DOI":"10.1038\/s41598-018-30098-1","volume":"8","author":"M Pi","year":"2018","unstructured":"Pi M, Ye R, Han X, Armstrong B, Liu X, Chen Y, Sun Y, Quarles LD (2018) Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II. Sci Rep 8:12398. https:\/\/doi.org\/10.1038\/s41598-018-30098-1","journal-title":"Sci Rep"},{"key":"1363_CR44","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/ndt\/gfw454","volume":"32","author":"M Leifheit-Nestler","year":"2017","unstructured":"Leifheit-Nestler M, Grabner A, Hermann L, Richter B, Schmitz K, Fischer DC, Yanucil C, Faul C, Haffner D (2017) Vitamin D treatment attenuates cardiac FGF23\/FGFR4 signaling and hypertrophy in uremic rats. Nephrol Dial Transplant 32:1493\u20131503. https:\/\/doi.org\/10.1093\/ndt\/gfw454","journal-title":"Nephrol Dial Transplant"},{"key":"1363_CR45","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1097\/hjh.0000000000001726","volume":"36","author":"P Palatini","year":"2018","unstructured":"Palatini P, Rosei EA, Avolio A, Bilo G, Casiglia E, Ghiadoni L, Giannattasio C, Grassi G, Jelakovich B, Julius S, Mancia G, McEniery CM, O\u2019Rourke MF, Parati G, Pauletto P, Pucci G, Saladini F, Strazzullo P, Tsioufis K, Wilkinson IB, Zanchetti A (2018) Isolated systolic hypertension in the young: a position paper endorsed by the European Society of Hypertension. J Hypertens 36:1222\u20131236. https:\/\/doi.org\/10.1097\/hjh.0000000000001726","journal-title":"J Hypertens"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-025-01363-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-025-01363-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-025-01363-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:20:37Z","timestamp":1766755237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-025-01363-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1363"],"URL":"https:\/\/doi.org\/10.1007\/s00223-025-01363-z","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dieter Haffner, Oliver Metzing, Annette Richter-Unruh and Dirk Schnabel received speaker fees, consultation fees, and research grants from Kyowa Kirin. Mirko Rehberg received speaker fees and consultation fees from Kyowa Kirin. Ulrike John-Kroegel, Maren Leifheit-Nestler and Ludwig Patzer received speaker fees from Kyowa Kirin. Ineke B\u00f6ckmann, Giuseppina Spart\u00e0, Katrina Evers, Karl Peter Schlingmann, Markus J. Kemper, Olaf Hiort, Karina Grohmann-Held, Ute Derichs, Clemens Freiberg, Marcus Weitz, Desiree Dunstheimer, Elmar Schmid, Sabine Heger, Norbert Jorch, Hagen Staude, Elke W\u00fchl, Miroslav Zivicnjak declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study\/registry was assessed and approved by the ethics committee of the Institutional Ethics Review Board at Hannover Medical School (No. 7259) and from each participating center and was performed according to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Patients and\/or parents\/guardians provided written informed consent and assent to participate in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}],"article-number":"56"}}